PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
20-Jan-2026 Medivir presenting at the Redeye Fight Cancer Event 2026 Medivir
20-Jan-2026 Levicept Announces FDA Acceptance of IND Application for LEVI-04, a Potentially Disease-Modifying Treatment for Osteoarthritis Levicept Ltd
20-Jan-2026 Atopia Therapeutics Reports Preclinical Proof-of-Concept of Lead Compound ATP-R13 in Atopic Dermatitis and Strengthens Patent Protection Atopia Therapeutics
20-Jan-2026 Vygon appoints new general manager to lead German subsidiary  Andrew Lloyd Associates
20-Jan-2026 Exciva raises €51 million ($59m) in Series B funding round co-led by Gimv and EQT Andrew Lloyd Associates
19-Jan-2026 Concept Life Sciences Appoints Dr Adam Davenport as CSO to Strengthen Leadership in Integrated Drug Discovery Concept Life Sciences
15-Jan-2026 Advanced Medical Solutions Group plc Full Year 2025 Trading Update Advanced Medical Solutions Group
15-Jan-2026 Sobi's 2025 annual revenue and adjusted EBITA margin exceed previous outlook Sobi
15-Jan-2026 Novo Nordisk Foundation grants DKK 5.5 billion to elevate innovation in Denmark and Europe Novo Nordisk Foundation
15-Jan-2026 Santhera Receives Swissmedic Approval of AGAMREE® (Vamorolone) for the Treatment of Duchenne Muscular Dystrophy Santhera
14-Jan-2026 BrainScope Expands Advisory Board with Appointment of Six Renowned Neuroscience Leaders BrainScope
14-Jan-2026 Thermo Fisher Scientific Launches Streamlined Workflow for Liver Cell Analysis Thermo Fisher Scientific
14-Jan-2026 Praxis Precision Medicines Appoints Global Epilepsy Leader Dr. Orrin Devinsky as Head of Clinical Strategy Praxis Precision Medicines
14-Jan-2026 Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners Genelux
14-Jan-2026 argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG argenx
14-Jan-2026 Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease Cassava
14-Jan-2026 Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects Moleculin
14-Jan-2026 TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Net Product Revenue and 2026 Revenue Guidance and Anticipated Development Milestones TG Therapeutics
14-Jan-2026 HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet HUTCHMED
13-Jan-2026 Alfasigma Secures Exclusive Rights from Innovative Molecules to Parenteral Adibelivir for Treatment of HSV Encephalitis, an Ultra-Rare Disease Alfasigma